StockLumo

Co-Diagnostics, Inc. (CODX): Form 8-K filed 2026-11-13

Accepted by EDGAR
2026-11-13 17:00 ET
Event date
2026-11-13
Accession no.
0001493152-26-051811
Original filing
SEC EDGAR filing index

AI summary of the filing text. It can contain mistakes; the original filing is authoritative.

Co-Diagnostics shareholders approve reverse stock split authority and equity plan expansion

At a court-ordered special meeting on November 13, 2026, Co-Diagnostics shareholders approved reverse stock split authority, an expanded equity incentive plan and financing-related share issuances. The Board may determine split ratios and timing within twelve months following the meeting. Shareholders also elected directors and approved executive compensation, auditor ratification and a quorum amendment.

shareholder votegovernancefinancing

Items reported

Documents

TypeDescriptionDocument
8-K8-Kform8-k.htm
EX-10.1EX-10.1ex10-1.htm

The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.